UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer

por Marcuello, E, Altés, A, Menoyo, A, del Rio, E, Gómez-Pardo, M, Baiget, M
Publicado 2004

A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer

por Marcuello, E, Páez, D, Paré, L, Salazar, J, Sebio, A, del Rio, E, Baiget, M
Publicado 2011

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

por Paré, L, Marcuello, E, Altés, A, Río, E del, Sedano, L, Salazar, J, Cortés, A, Barnadas, A, Baiget, M
Publicado 2008

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

por Paré, L, Marcuello, E, Altés, A, del Río, E, Sedano, L, Salazar, J, Cortés, A, Barnadas, A, Baiget, M
Publicado 2009

Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer

por Palicio, M, Blanco, I, Tórtola, S, González, I, Marcuello, E, Brunet, J, Lluis, F, González-Aguilera, J J, Peinado, M A, Capella, G
Publicado 2000

Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer

por del Muro, X García, Marcuello, E, Gumá, J, Paz-Ares, L, Climent, M A, Carles, J, Parra, M Sánchez, Tisaire, J L, Maroto, P, Germá, J R
Publicado 2002

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

por Martinez-Balibrea, E, Abad, A, Martínez-Cardús, A, Ginés, A, Valladares, M, Navarro, M, Aranda, E, Marcuello, E, Benavides, M, Massutí, B, Carrato, A, Layos, L, Manzano, J L, Moreno, V
Publicado 2010